Corticosteroid-induced osteoporosis

Clinical criteria:

• The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient,

AND

• Patient must currently be on long-term (at least 3 months), high-dose (at least 7.5 mg per day prednisolone or equivalent) corticosteroid therapy,

AND

• Patient must have a Bone Mineral Density (BMD) T-score of -1.5 or less,

AND

• Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.

The duration and dose of corticosteroid therapy together with the date, site (femoral neck or lumbar spine) and score of the qualifying BMD measurement must be documented in the patient's medical records when treatment is initiated.

Osteoporosis

Clinical criteria:

• The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.

Population criteria:

• Patient must be aged 70 years or older.

Clinical criteria:

• Patient must have a Bone Mineral Density (BMD) T-score of -2.5 or less,

AND

• Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.

The date, site (femoral neck or lumbar spine) and score of the qualifying BMD measurement must be documented in the patient's medical records when treatment is initiated.

Established osteoporosis

Clinical criteria:

• The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient,

AND

• Patient must have fracture due to minimal trauma,

AND

• Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.

The fracture must have been demonstrated radiologically and the year of plain x-ray or computed tomography (CT) scan or magnetic resonance imaging (MRI) scan must be documented in the patient's medical records when treatment is initiated.

A vertebral fracture is defined as a 20% or greater reduction in height of the anterior or mid portion of a vertebral body relative to the posterior height of that body, or, a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.